- Report
- March 2024
- 198 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- October 2023
- 190 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- January 2022
- 200 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Report
- March 2022
- 120 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- July 2023
- 85 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Drug Pipelines
- August 2019
- 54 Pages
Global
From €1930EUR$2,000USD£1,656GBP
The Hypotension Drug market is a subset of the Cardiovascular Drugs market, which includes drugs used to treat conditions related to the heart and circulatory system. Hypotension Drugs are used to treat low blood pressure, a condition in which the force of the blood against the artery walls is too low. These drugs work by increasing the amount of blood pumped by the heart, increasing the diameter of the blood vessels, and reducing the amount of fluid in the body. Commonly prescribed Hypotension Drugs include diuretics, ACE inhibitors, calcium channel blockers, and alpha-blockers.
Some of the major companies in the Hypotension Drug market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more
